Trial Profile
Ovarian response to Corifollitropin Alfa in a GnRH-antagonist multiple-dose protocol
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Apr 2020
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Gonadotropin releasing hormone inhibitors
- Indications Infertility
- Focus Biomarker; Therapeutic Use
- 18 Apr 2018 New trial record